CliffBio
small molecule

VARUBI

ROLAPITANT HYDROCHLORIDE

Loss of exclusivityOctober 2029latest FDA-listed patent expiry
CompanyTersera Therapeutics →See this company's full patent-cliff portfolio

Drug detail

Brand nameVARUBI
Active ingredientROLAPITANT HYDROCHLORIDE
StrengthEQ 90MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2015
Marketing statusRX

Listed patents

PatentExpiresType
8361500October 2029product
8470842January 2029use U-1741
7049320August 2028substance, product
7981905April 2027use U-1741
7563801April 2027product
8404702April 2027use U-1741
8178550April 2027substance, product

More from Tersera Therapeutics

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.